Research use only · Multi-region fulfillment · Support-assisted ordering
VestaResearch Supply
Eltromag 50mg Tablets | 105-Count | ELTROMBOPAG
Pharma

Eltromag 50mg Tablets | 105-Count | ELTROMBOPAG

$310

In stock

For in vitro laboratory research only. Not for human or veterinary consumption.

India Warehouse ELTROMBOPAG — 50mg per tablet, 105-count pack. Thrombopoietin receptor agonist for chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia. Key warning: LFT monitoring mandatory every 2 weeks during titration, then monthly. Thrombosis risk — use minimum effective dose. Avoid antacids within 4 hours (reduces absorption dramatically). Cataract monitoring.

SKU
VES-007973-ELTROMAG-50MG-105TAB
Format
N/A
Use
Laboratory research only
Ask on Telegram

What is Eltromag 50mg (1X7) (ELTROMBOPAG)?

Thrombopoietin receptor agonist for chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, and severe aplastic anemia.

How it Works

Non-peptide TPO receptor agonist binding the transmembrane domain of the TPO receptor on megakaryocyte progenitors — stimulates platelet production.

Quick Specs

Form
Oral tablets — pre-dosed
Active Ingredient
ELTROMBOPAG
Dose per Tablet
50MG
Pack Size
105 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)

Common Side Effects

Hepatotoxicity (mandatory LFT monitoring), cataracts, thromboembolic events, reticulin fibrosis with long-term use, QT prolongation.

Safety Warnings

LFT monitoring mandatory every 2 weeks during titration, then monthly. Thrombosis risk — use minimum effective dose. Avoid antacids within 4 hours (reduces absorption dramatically). Cataract monitoring. International shipping: 7–14 days

Research use only

This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.